General Information
Revision date
2020-01-17
Product name
Kurvelo Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/30 mcg
CAS No.
797-63-7
Manufacturer Name
Lupin Limited
Icons in SDS
Company Information
company name
Lupin Limited
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Kurvelo is contraindicated in females who are known to have the following conditions: A high risk of arterial or venous thrombotic diseases. Examples include women who are known to: Smoke, if over age 35 Have current or history of deep vein thrombosis or pulmonary embolism. Have cerebrovascular disease. Have coronary artery disease. Have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation). Have inherited or acquired hypercoagulopathies. Have uncontrolled hypertension or hypertension with vascular disease. Have diabetes mellitus and are over age 35, diabetes mellitus with hypertension or vascular disease or other end-organ damage, or diabetes mellitus of >20 years duration. Have headaches with focal neurological symptoms, migraine headaches with aura, or over age 35 with any migraine headaches. Current or history of breast cancer or other estrogen- or progestin-sensitive cancer. Liver tumors, acute viral hepatitis, or severe (decompensated) cirrhosis. Use of Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations. Undiagnosed abnormal uterine bleeding. Pregnancy, because there is no reason to use COCs during pregnancy.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.